NYSE:WX

Fosun Pharma, HOPU Investments, CEL Healthcare Fund, and WuXi PharmaTech to Jointly Acquire U.S. Innovative Biotechnology Company Ambrx

SHANGHAI, May 22, 2015 /PRNewswire/ -- A consortium ("the Consortium") consisting of entities affiliated with Shanghai Fosun Pharmaceutical Group, HOPU Investments, China Everbright Limited's healthcare fund ("CEL Healthcare Fund"), and WuXi PharmaTech announced today that the Consortium has sign...

2015-05-22 07:00 3760

WuXi PharmaTech Announces First-Quarter 2012 Results

SHANGHAI, May 10, 2012 /PRNewswire-Asia/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading research and development outsourcing company serving the pharmaceutical, biotechnology, and medical device industries, with operations in China and the United States, today announced its financial results...

2012-05-11 04:30 1141

WuXi PharmaTech Files 2011 Annual Report on Form 20-F

SHANGHAI, April 20, 2012 /PRNewswire-Asia/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX) today announced that it filed its annual report on Form 20-F for the year ended December 31, 2011 with the Securities and Exchange Commission. The annual report can be accessed on WuXi PharmaTech's website at http...

2012-04-21 02:47 906

WuXi PharmaTech Schedules First-Quarter 2012 Earnings Release

SHANGHAI, April 17, 2012 /PRNewswire-Asia/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading pharmaceutical, biotechnology and medical device R&D outsourcing company with operations in China and the United States, today announced that it will release financial results for the first quarter ...

2012-04-17 21:09 778

WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2011 Results, Share Repurchase Program

SHANGHAI, March 8, 2012 /PRNewswire-Asia/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading research and development outsourcing company serving the pharmaceutical, biotechnology, and medical device industries, with operations in China and the United States, today announced its financial result...

2012-03-09 05:30 942

WuXi PharmaTech Announces Purchase of Ordinary Shares from General Atlantic

SHANGHAI, Feb. 15, 2012 /PRNewswire-Asia/ -- WuXi PharmaTech (NYSE: WX), a leading pharmaceutical, biotechnology, and medical-device research and development outsourcing company, with operations in China and the United States, announced that today it had in a negotiated transaction agreed to purchas...

2012-02-15 17:01 959

WuXi PharmaTech Schedules Fourth-Quarter 2011 Earnings Release

SHANGHAI, Feb. 8, 2012 /PRNewswire-Asia / -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading pharmaceutical, biotechnology and medical device R&D outsourcing company with operations in China and the United States, today announced that it will release financial results for the fourth quarter ...

2012-02-08 22:00 1048

WuXi PharmaTech Announces Third-Quarter 2011 Results

SHANGHAI, Nov. 10, 2011 /PRNewswire-Asia/ -- *WuXi PharmaTech** (Cayman) Inc.* (NYSE: WX), a leading research and development outsourcing company serving the pharmaceutical, biotechnology, and medical device industries, with operations in China and the United States, today announced its financial re...

2011-11-11 05:30 1168

WuXi PharmaTech Schedules Third-Quarter 2011 Earnings Release

SHANGHAI, Oct. 25, 2011 /PRNewswire-Asia/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading pharmaceutical, biotechnology and medical device R&D outsourcing company with operations in China and the United States, today announced that it will release financial results for the third quarter o...

2011-10-26 01:07 1074

WuXi PharmaTech Acquires China-Based Clinical Research Services Companies

SHANGHAI, Oct. 24, 2011 /PRNewswire-Asia/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading pharmaceutical, biotechnology and medical device research and development services company with operations in China and the United States, today announced the acquisition of MedKey Med-Tech Development C...

2011-10-24 20:00 1036

WuXi PharmaTech Acquires Abgent, a Leading Producer of Biological Research Reagents

SHANGHAI, Oct. 13, 2011 /PRNewswire-Asia/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading pharmaceutical, biotechnology and medical device research and development services company with operations in China and the United States, today announced the acquisition of Abgent, Inc., a provider of b...

2011-10-14 09:00 1601

WuXi PharmaTech Announces Resignation of Board Member Cuong Viet Do

SHANGHAI, Sept. 30, 2011 /PRNewswire-Asia/ --WuXi PharmaTech (Cayman) Inc. (NYSE: WX) today announced that Cuong Viet Do is stepping down from WuXi's board of directors effective immediately. Mr. Do has been appointed Chief Strategy Officer of Merck and Company, which is a large WuXi customer. "I ...

2011-09-30 23:56 1252

WuXi PharmaTech Announces Second Quarter 2011 Results

SHANGHAI, Aug. 10, 2011 /PRNewswire-Asia/ -- *WuXi PharmaTech** (Cayman) Inc.* (NYSE: WX), a leading research and development outsourcing company serving the pharmaceutical, biotechnology, and medical device industries, with operations in China and the United States, today announced its financial re...

2011-08-11 04:30 1235

WuXi PharmaTech Announces Shareholder Resolutions Adopted at 2011 Annual General Meeting

SHANGHAI, Aug. 9, 2011 /PRNewswire-Asia/ -- *WuXi PharmaTech (Cayman) Inc.* (NYSE: WX) today announced shareholder resolutions adopted at its annual general meeting of shareholders held in Hong Kong on August 9, 2011. At the meeting, WuXi PharmaTech shareholders approved the re-election of incumben...

2011-08-09 23:29 1103

WuXi PharmaTech Schedules Second-Quarter 2011 Earnings Release

SHANGHAI, July 19, 2011 /PRNewswire-Asia/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading pharmaceutical, biotechnology and medical device R&D outsourcing company with operations in China and the United States, today announced that it will release financial results for the second quarter ...

2011-07-19 23:33 1023

WuXi AppTec Named a Top Ten Chinese Outsourcing Enterprise

Dr. Ge Li, Chairman and CEO, Named a Top Ten Contributor to China's Outsourcing Industry SHANGHAI, June 16, 2011 /PRNewswire-Asia/ -- WuXi AppTec announced today that it has been selected as one of the Top Ten Outsourcing Enterprises in China for 2011 by China's Ministry of Commerce. The list was...

2011-06-16 16:17 1473

WuXi PharmaTech Announces First-Quarter 2011 Results

SHANGHAI, May 11, 2011 /PRNewswire-Asia/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading research and development outsourcing company serving the pharmaceutical, biotechnology, and medical device industries, with operations in China and the United States, today announced its financial results...

2011-05-11 04:30 1230

WuXi PharmaTech Files 2010 Annual Report on Form 20-F

SHANGHAI, April 27, 2011 /PRNewswire-Asia/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX) today announced that it filed its annual report on Form 20-F for the year ended December 31, 2010 with the Securities and Exchange Commission. The annual report can be accessed on WuXi PharmaTech's website at http...

2011-04-27 19:33 1129

WuXi PharmaTech Schedules First-Quarter 2011 Earnings Release

SHANGHAI, April 20, 2011 /PRNewswire-Asia/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading pharmaceutical, biotechnology and medical device R&D outsourcing company with operations in China and the United States, today announced that it will release financial results for the first quarter of 2...

2011-04-20 04:19 983

WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2010 Results

SHANGHAI, March 9, 2011 /PRNewswire-Asia/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading research and development outsourcing company serving the pharmaceutical, biotechnology, and medical device industries, with operations in China and the United States, today announced its financial result...

2011-03-09 05:30 1208
12345 ... 8